Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #5129 on GTC Biotherapeutics (fka GTCB)
Isotope Feeney
10/03/07 10:43 AM
#5132 RE: DewDiligence #5129
DewDiligence
12/10/07 5:10 PM
#6047 RE: DewDiligence #5129
Executive Officers Geoffrey Cox, CEO 266K shares 722K options John Green, CFO 109K shares 307K options Harry Meade, SVP Research 107K shares 268K options Dan Woloshen, Gen. Counsel 81K shares 190K options Greg Liposky, SVP Oprtns 51K shares 246K options Dick Scotland, SVP Regltry 69K shares 129K options -- Six executive officers 683K shares 1,852K options
Non-executive directors Robert Baldridge 5K shares 75K options Kenneth Bauer 0 shares 38K options Christian Béchon 13K shares 15k options Francis Bullock 9K shares 74K options James Geraghty 75K shares 163K options Michael Landine 0 shares 38K options Pamela McNamara 8K shares 53K options Marvin Miller 7K shares 53K options Alan Tuck 13K shares 51K options Mary Ann Gray 1K shares 15K options -- Ten non-executive directrs 131K shares 575K options
All officers/directors 814K shares 2,427K options